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Introduction: Case series have been a long held tradition within the surgical literature and are still
frequently published. Reporting guidelines can improve transparency and reporting quality. No guideline
exists for reporting case series, and our recent systematic review highlights the fact that key data are
being missed from such reports. Our objective was to develop reporting guidelines for surgical case
series.
Methods: A Delphi consensus exercise was conducted to determine items to include in the reporting
guideline. Items included those identiﬁed from a previous systematic review on case series and those
included in the SCARE Guidelines for case reports. The Delphi questionnaire was administered via Google
Forms and conducted using standard Delphi methodology. Surgeons and others with expertise in the
reporting of case series were invited to participate. In round one, participants voted to deﬁne case series
and also what elements should be included in them. In round two, participants voted on what items to
include in the PROCESS guideline using a nine-point Likert scale to assess agreement as proposed by the
Grading of Recommendations, Assessment, Development and Evaluations (GRADE) working group.
Results: In round one, there was a 49% (29/59) response rate. Following adjustment of the guideline with
incorporation of recommended changes, round two commenced and there was an 81% (48/59) response
rate. All but one of the items were approved by the participants and Likert scores 7-9 were awarded by
>70% of respondents. The ﬁnal guideline consists of an eight item checklist.
Conclusion: We present the PROCESS Guideline, consisting of an eight item checklist that will improve
the reporting quality of surgical case series. We encourage authors, reviewers, editors, journals, pub-
lishers and the wider surgical and scholarly community to adopt these.
© 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Case series often appear in the surgical and wider healthcare
literature but also in social sciences and the humanities [3]. Dekkersby Elsevier Ltd. This is an open accet al. deﬁned a case series as an uncontrolled study that either
samples participants with both a speciﬁc intervention (exposure)
and a speciﬁc outcome, or samples participants with a speciﬁc
outcome of interest regardless of their exposure status [1]. A series
sampled only on exposure is a cohort study. A report of a case series
is commonly a retrospective review of a string of patients with a
unifying feature - be that exposure (including treatment) or
outcome, or both. There has also been signiﬁcant confusioness article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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As with case reports, their value has been debated [3,4]. In the
age of evidence-based medicine (EBM), with the randomised
controlled trial as the standard to show the efﬁcacy of a particular
treatment, what is their role? Level four evidence was still the
most common study type in a bibliometric analysis of research
published in 2013 in the specialties of plastic surgery, orthopaedic
surgery, otolaryngology and neurosurgery, with signiﬁcant outputs
in maxillo-facial surgery (33%) and vascular surgery (15%) [5]. The
use of a case series in the recognition of a new disease was
exempliﬁed in 1999 by the epidemic of West Nile encephalitis in
New York [6]. Historically, case series were important in identi-
fying the impact of maternal drinking and pregnancy outcome and
the role of vitamin C in preventing scurvy [7,8]. A single case series
can lead to very signiﬁcant change, from the widespread use of
negative pressure dressings following a case series of 10 patients
[9] to a 49 patient case series that led to a new classiﬁcation
system for haemangiomas and vascular malformations in 1982,
still in use today [10].
Albrecht et al. studied reports of case series and found that a
high proportion led to follow-up trials and that they were useful in
establishing an early evidence base for new treatments of rare
diseases in which trials would not be feasible [11]. For some spe-
cialties, establishing control groups may be difﬁcult, such as in
accident and emergency medicine or paediatric medicine or sur-
gery. In the social sciences, many social psychology studies have
been case series, for example Yale psychologist Stanley Milgram's
seminal work on obedience to authority ﬁgures [12].
In a 2005 report, Dalziel et al. found that case series were used in
30% of Health Technology Assessments (HTA) used in the provision
and suitability of care [13]. Poor reporting in the case series
included in their study, however, severely constrained their anal-
ysis and investigation of the hypothesis that ﬁndings in case series
may be affected by methodological characteristics [10]. Readers
need complete, transparent information in all reports of research.
Poor reporting of case series undermines critical appraisal,
assessment of external validity and whether, for instance, surgeons
should change their practice.
No standardised reporting criteria have been developedwithin a
robust methodological framework for case series. The aim of the
present study was to close this gap and produce a reporting
guideline for case series that is methodologically robust, easy to
use, and accepted internationally across a broad range of specialties
and disciplines. Following guidance on guideline development, the
early steps in this process require an analysis of previous literature
to identify previous guidance (if any) and to analyse relevant evi-
dence on the quality of reporting of published research articles
within the domain of interest [14]. Our group recently completed a
systematic review on the reporting quality of case series in surgery
over the period 1990e2014 [15]. From 92 articles that met the in-
clusion criteria, methodological and reporting issues identiﬁed
were: failure to use standardised deﬁnitions (57%), missing or se-
lective data (66%), lack of transparency or incomplete reporting
(70%), whether alternative study designs were considered (11%)
and other issues (52%) such as failure to clearly deﬁne the patient
population under investigation, selection bias, insufﬁcient follow-
up time, need for validated outcomes.
We recently developed the SCARE Guidelines for Case Reports
using a DELPHI consensus exercise, which have now been adopted
by several journals [16]. Following this experience, the objective of
this research was to conduct a Delphi consensus exercise amongst
experienced surgical case series reviewers and editors to develop
the Preferred Reporting Of CasE Series in Surgery (PROCESS)
Guideline.2. Developing the PROCESS guideline
We issued a survey using Google Forms (https://www.google.co.
uk/forms/about) asking participants in round one to help deﬁne
surgical case series and what items should be included in them. In a
subsequent round, participants were asked to rate their level of
agreement with the guideline items from round one as well as
items from the SCARE guidelines and any additional items that
were suggested using a nine-point Likert scale as proposed by the
GRADE group [17]. In this scale 1 to 3 signiﬁes an outcome of
limited importance, 4 to 6 important but not critical and 7 to 9
critical. If 70% or more of respondents scored an item 7 to 9 and
fewer than 15% scored it 1 to 3, that item was incorporated in the
reporting guideline. Similarly, consensus that an outcome should
not be included was 70% or more scoring it 1 to 3 and 15% or less
scoring it 7 to 9. The entire process was conducted electronically
and there was no pre-determined number of Delphi rounds.
3. Participant selection
Surgeons and others with signiﬁcant experience in reviewing or
editing case reports were selected. They were drawn from the
reviewer pool of IJS Case Reports (the top 150 were invited) as well
as those who have written on the topic of case series and case re-
ports in the past. In total 59 participants agreed to the invitation to
participate in this study, representing 21 countries and all ten
surgical specialties as well as allied specialties including; derma-
tology, pathology, oncology, clinical pharmacology, acute care sur-
gery, with many participants also occupying positions on journal
editorial boards [18].
4. Results
In round 1, there was a 49% (29/59) response rate. The partici-
pant responses are integrated into Table 1.
Following adjustment of the guideline with incorporation of
recommended changes, round 2 commenced (see Tables 2 and 3).
There was an 81% (48/59) response rate. All guideline items were
approved by the participants with Likert scores 7e9 awarded by
>70% of respondents, apart from “4a - registration and ethics - state
the research registry number in accordance with the declaration of
Helsinki”, which had scores of 7e9 from 65% of participants.
However, as this item is part of the declaration of Helsinki, it cannot
be removed or augmented.
5. PROCESS guideline
Table 3 constitutes the PROCESS guideline, and this is provided
again in an Appendix, together with a column in which the author
can state the page number onwhich the criterionwas achieved. We
recommend that all authors submitting case series should submit a
completed PROCESS checklist with their manuscript and also state
explicitly in their report that they have complied with the PROCESS
guideline, which they should cite in their paper. The guideline
represents the minimum of what should be reported and we
encourage authors to provide additional details that are relevant.
So, when should a case series be performed and when should these
guidelines be used? For surgical case series speciﬁcally, the
following can also be advocated: rare diseases or rare circum-
stances (such as emergencies), logistical difﬁculties or where
ethical issues may arise with prospective randomised studies e.g.
paediatric populations, new diseases e their description, natural
history and management, studying the mechanism of disease and
studying the impact of established procedures. In addition, late or
delayed effects following surgical interventions, such as biliary
Table 1
DELPHI round 1 responses.
Question Responses (n ¼ 29)
We are deﬁning a case series as follows: A case series is a descriptive study of an
uncontrolled group of patients who are sampled on the basis of a speciﬁc
exposure/intervention or a speciﬁc outcome of interest regardless of their
exposure status
62.1% agree (18/29)
37.9% disagree (11/29)
Comments e should be mentioned they are observational studies and they may
relate to a speciﬁc disease.
How do you differentiate a case series from a cohort study? Should a Cohort
study always have two or more groups? Other reasons?
Both are observational studies but cohort studies are comparative and patients
in them are always sampled on the basis of exposure, whereas case series may
be sampled on the basis of; disease/exposure/intervention or a speciﬁc outcome
of interest
What are the important elements that should be reported in a case series?
 What is the unifying theme - common presentation, diagnosis, intervention,
outcome, etc
93% (27/29)
 Whether it is prospective or retrospective Whether alternative study designs
were considered e.g. cohort, RCT, etc
76% (22/29)
 Whether alternative study designs were considered e.g. cohort, RCT, etc 31% (9/29)
 Whether the cases are consecutive or not 86% (25/29)
 Whether it is multi centre or single centre 90% (26/29)
 What the time interval over which cases were collected giving years and
potentially months as well if collected over a short period of time
90% (26/29)
 Patient population should detailed 90% (26/29)
 Patient selection should be described in detail 83% (24/29)
 Changes to the intervention during the course of the series should be detailed 6% (25/29)
 A comment on learning curves should be made for new techniques 72% (21/29)
 Loss to follow-up should be detailed e.g. % of sample lost to follow-up and
reasons if known
83% (24/29)
 Other elements not already included in the SCARE checklist (please state) 28% (8/29)
Other than the items above and those in the SCARE checklist, please let us know
if anything else should be reported in a case series?
Why cases were non-consecutive.
State if patients were excluded.
Table 2
DELPHI round 2 responses to deﬁnitions.
Question Responses (n ¼ 46) and comments
From the ﬁrst round results, a case series is being deﬁned as: “an observational study of
an uncontrolled group of patients collected or sampled on the basis of a speciﬁc
disease/exposure/intervention or a speciﬁc outcome of interest.”
96% (44/46)
A Case Series must be differentiated from a Cohort Study so we have deﬁned those to
following the ﬁrst round results. “A Cohort Study is a comparative study typically
involving two or more groups of patients that are sampled only on the basis of a
speciﬁc exposure or intervention.” This deﬁnition is similar to that put forward by the
Centre of Evidence Based Medicine at Oxford University: http://www.cebm.net/
glossary/.
76% (35/46)
A single group cohort may still be utilised e.g. for prognostic studies.
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a case series. Where a new technique or device has been conceived
and requires development and assessment, the IDEAL (Idea,
Development, Exploration, Assessment and Long-term follow-up)
framework is recommended [19].6. Endorsement
The PROCESS guideline has been endorsed by the IJS, IJS Case
Reports, IJS Open, Annals of Medicine and Surgery, IJS Oncology,
and IJS Short Reports.7. Conclusion
After completion of two DELPHI rounds consensus was reached
among a multidisciplinary and expert group in the area of surgery
and case series. If used appropriately, the PROCESS guidelines will
aid in raising the reporting quality of surgical case series. We
encourage authors, reviewers, editors, journals, publishers and the
wider surgical and scholarly community to adopt these. We look
forward to feedback from the community as well as studies of its
implementation to help inform a future revision of these
guidelines.8. PROCESS group participants
The following people contributed to the PROCESS Guideline:
Raafat Aﬁﬁ, Cairo University, Raha Alahmadi, King Faisal Specialist
Hospital and Research Centre, Joerg Albrecht, John H. Stroger Jr.
Hospital of Cook County, Abdulrahman Alsawadi, Colchester Hos-
pital University NHS Foundation Trust, Jeffrey K. Aronson, Radcliffe
Inﬁrmary, Oxford, M. Hammad Ather, Aga Khan University,
Mohammad Bashashati, Texas Tech University Health Sciences
Centre, Somprakas Basu, Banarus Hindu University, Patrick Bradley,
Nottingham University Hospitals, Mushtaq Chalkoo, Govt. medical
college, Srinagar Kashmir, Ben Challacombe, Guy's and St Thomas'
NHS Foundation Trust, Trent Cross, James Cook University, Laura
Derbyshire, North West Deanery, Naheed Farooq, Central Man-
chester University Hospital Foundation Trust, Jerome Hoffman,
University of California Los Angeles, Huseyin Kadioglu, Bezmialem
Vakif University, Veeru Kasivisvanathan, University College London,
Boris Kirshtein, Soroka University Medical Centre, Roberto Klap-
penbach, Simplemente Evita Hospital, Daniel Laskin, Virginia
Commonwealth University, Diana Miguel, University Hospital Jena,
James Milburn, Queens Medical Centre, Oliver Muensterer, Uni-
versity Medicine Mainz, James Ngu, Changi General Hospital, Iain
Nixon, East Kent University Hospitals, Ashraf Noureldin, Cumber-
land Royal Inﬁrmary, Benjamin Perakath, Dr. Gray's Hospital,
Table 3
DELPHI round 2 responses to guideline items.
Section Item Checklist Description Responses (n ¼ 48)
Scores 7-9
Title 1 The words “case series” and the area of focus should appear in the title (e.g. disease, exposure/intervention or
outcome).
80% (37/46)
Abstract 2a Introduction
What is the unifying theme of the case series.
89% (41/46)
2b Methods
Describe what was done, how and when was it done and by whom.
2c Results
What was found.
2d Conclusion
What have we learned and what does it mean
Introduction 3 Explain the scientiﬁc background and rationale for the case series. What is the unifying theme - common
disease, exposure, intervention and outcome, etc. Why is this study needed?
96% (44/46)
Methods 4a Registration and ethics
State the research registry number in accordance with the declaration of Helsinki - “Every research study
involving human subjects must be registered in a publicly accessible database before recruitment of the ﬁrst
subject” (this can be obtained from; ResearchRegistry.com or ClinicalTrials.gov or ISRCTN). Even retrospective
studies should be registered prior to submission. State whether ethical approval was needed and if so, what the
relevant judgement reference from the IRB or local ethics committee was? If ethical approval was not needed,
state why.
65% (30/46)
4b Study design
State the study is a case series and whether prospective or retrospective in design, whether single or multi-
centre and whether cases are consecutive or non-consecutive.
91% (42/46)
4c Setting
Describe the setting(s)and nature of the institution in which the patient was managed; academic, community or
private practice setting? Location(s), and relevant dates, including periods of recruitment, exposure, follow-up,
and data collection
87% (40/46)
4d Participants
Describe the relevant characteristics of the participants (comorbidities, tumour staging, smoking status, etc).
State any eligibility (inclusion/exclusion) criteria and the sources and methods of selection of participants.
Describe length and methods of follow-up.
93% (43/46)
4e Pre-intervention considerations
e.g. Patient optimisation: measures taken prior to surgery or other intervention e.g. treating hypothermia/
hypovolaemia/hypotension in burns patients, ICU care for sepsis, dealing with anticoagulation/other
medications and so on.
80% (37/46)
4f Types of intervention(s) deployed
To include reasoning behind treatment offered (pharmacological, surgical, physiotherapy, psychological,
preventive) and concurrent treatments (antibiotics, analgesia, anti-emetics, nil by mouth, VTE prophylaxis, etc).
Medical devices should have manufacturer and model speciﬁcally mentioned.
87% (40/46)
4g Peri-intervention considerations
Administration of intervention (what, where, when and how was it done, including details for surgery;
anaesthesia, patient position, use of tourniquet and other relevant equipment, preparation used, sutures,
devices, surgical stage (1 or 2 stage, etc) and operative time. Pharmacological therapies should include
formulation, dosage, strength, route and duration). Authors are encouraged to use ﬁgures, diagrams, photos,
video and other multimedia to explain their intervention.
89% (41/46)
4h Who performed the procedure(s)
Operator experience (position on the learning curve for the technique if established, specialisation and prior
relevant training).
83% (38/46)
4i Quality control
What measures were taken to reduce inter or intra-operator variation. What measures were taken to ensure
quality and consistency in the delivery of the intervention e.g. independent observers, lymph node counts, etc
76% (35/46)
4j Post-intervention considerations
e.g. post-operative instructions and place of care. Important follow-up measures - diagnostic and other test
results. Future surveillance requirements - e.g. imaging surveillance of endovascular aneurysm repair (EVAR) or
clinical exam/ultrasound of regional lymph nodes for skin cancer.
89% (41/46)
Results 5a Participants
Report numbers involved and their characteristics (co-morbidities, tumour staging, smoking status, etc).
96% (44/46)
5b Changes
Any changes in the interventions during the course of the case series (how has it evolved, been altered or
tinkered with, what learning occurred, etc) together with rationale and a diagram if appropriate. Degree of
novelty for a surgical technique/device should be mentioned and a comment on learning curves should bemade
for new techniques/devices.
89% (41/46)
5c Outcomes and follow-up
Clinician assessed and patient-reported outcomes (when appropriate) should be stated with inclusion of the
time periods at which assessed. Relevant photographs/radiological images should be provided e.g. 12-month
follow-up.
93% (43/46)
5d Intervention adherence/compliance and tolerability
Howwas this assessed. Describe loss to follow-up (express as a percentage and a fraction) and any explanations
for it.
91% (42/46)
5e Complications and adverse or unanticipated events
Described in detail and ideally categorised in accordance with the Clavien-Dindo Classiﬁcation. How they were
prevented, mitigated, diagnosed and managed. Blood loss, wound complications, re-exploration/revision
surgery, 30-day post-op and long-term morbidity/mortality may need to be speciﬁed.
89% (41/46)
Discussion 6a Summarise key results 93% (43/46)
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Table 3 (continued )
Section Item Checklist Description Responses (n ¼ 48)
Scores 7-9
6b Discussion of relevance
Relevant literature, implications for clinical practice guidelines, how have the indications for a new technique/
device been reﬁned and how do outcomes compare with established therapies and the prevailing gold standard
should one exist and any relevant hypothesis generation.
91% (42/46)
6c Strengths and limitations of the study 93% (43/46)
6d The rationale for any conclusions? 96% (44/46)
Conclusions 7a State the key conclusions from the study 93% (43/46)
7b State what needs to be done next, further research with what study design. 78% (36/46)
Additional
information
8a State any conﬂicts of interest 98% (45/46)
8b State any sources of funding 96% (44/46)
R.A. Agha et al. / International Journal of Surgery 36 (2016) 319e323 323Nicholas Raison, King's College London, Kandiah Raveendran,
Fatimah Hospital, Timothy Sullivan, Minneapolis Heart Institute,
Achilleas Thoma, McMaster University, Mangesh A. Thorat, Wolfson
Institute of Preventative Medicine, Queen Mary University of
London, Andy Petroianu, Federal University of Minas Gerais,
Ashwini Rao, Manipal College of Dental Sciences, Mangalore,
Manipal University, Michele Valmasoni, Universita di Padova,
Samuele Massarut, Centro di Riferimento Oncologico Aviano Italy,
Anil D'cruz, Tata Memorial Hospital, Baskaran Vasudevan, MIOT
Hospitals, Salvatore Giordano, Turku University Hospital, Donagh
Healy, University Hospital Waterford, David Machado-Aranda,
University of Michigan, Frederick H. Millham, Newton-Wellesley
Hospital, Bryan Carroll, Eastern Virginia Medical School, Indra-
neilm Mukherjee, Florida Hospital Tampa, Peter McCulloch, Uni-
versity of Oxford, Yasuhiko Sugawara, Japanese Red Cross Hospital
and David Rosin, University of West Indies.Ethical approval
Not applicable.Sources of funding
Paton Masser Memorial Fund Prize awarded by British Associ-
ation of Plastic, Reconstructive and Aesthetic Surgeons and Balliol
Interdisciplinary Institute Grant. None of the authors has a ﬁnancial
interest in any of the products, devices or drugs mentioned in this
manuscript.Author contribution
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